These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 13102579)

  • 21. The treatment of sleeping sickness (mainly due to Trypanosoma rhodesiense) with melarsoprol. I. Reactions observed during treatment.
    ROBERTSON DH
    Trans R Soc Trop Med Hyg; 1963 Mar; 57():122-33. PubMed ID: 13974350
    [No Abstract]   [Full Text] [Related]  

  • 22. [New contribution on arsobal (R.P. 3854) therapy of trypanosomiasis; its effectiveness in former trypanosomiasis patients, with meningoencephalitis, resistant to trypanocides customarily used].
    CECCALDI J
    Bull Soc Pathol Exot Filiales; 1953; 46(1):95-121. PubMed ID: 13066959
    [No Abstract]   [Full Text] [Related]  

  • 23. [EEG and treatment with Arsobal in human African trypanosomiasis].
    Giordano C; Boa FY; Kouassi B; Piquemal M; Akani F; Yapi P; Sonan T
    Bull Soc Pathol Exot Filiales; 1988; 81(3 Pt 2):482-3. PubMed ID: 3197245
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical Mel B, resistance in Rhodesian sleeping sickness.
    Ogada T
    East Afr Med J; 1974 Jan; 51(1):56-9. PubMed ID: 4839238
    [No Abstract]   [Full Text] [Related]  

  • 25. Treatment of Rhodesian sleeping sickness in Kenya.
    Wellde BT; Chumo DA; Reardon MJ; Abinya A; Wanyama L; Dola S; Mbwabi D; Smith DH; Siongok TA
    Ann Trop Med Parasitol; 1989 Aug; 83 Suppl 1():99-109. PubMed ID: 2619399
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Arsenical resistance and difluoromethylornithine in the treatment of human African trypanosomiasis].
    Kazyumba GL; Ruppol JF; Tshefu AK; Nkanga N
    Bull Soc Pathol Exot Filiales; 1988; 81(3 Pt 2):591-4. PubMed ID: 3143492
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of Mel B arsobal and alpha-difluoromethylornithine on the awakening electroencephalogram of humans with gambiense trypanosomiasis disease: preliminary report.
    Hamon JF; Seri B; Doua F; Camara P; Aba L
    Pharmacol Biochem Behav; 1990 Aug; 36(4):831-5. PubMed ID: 2217510
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Treatment of African trypanosomiasis by pentylthiarsaphenylmelamine].
    SCHNEIDER J; LEVEUF JJ; TANGARA S
    Bull Soc Pathol Exot Filiales; 1961; 54():345-65. PubMed ID: 13748225
    [No Abstract]   [Full Text] [Related]  

  • 29. [Current status of the therapy of human African trypanosomiasis].
    Dumas M; Breton JC; Pestre Alexandre M; Girard PL; Giordano C
    Presse Med; 1985 Feb; 14(5):253-6. PubMed ID: 3157106
    [No Abstract]   [Full Text] [Related]  

  • 30. [Treatment of African trypanosomiasis (sleeping sickness)].
    SCHNEIDER J
    Presse Med (1893); 1960 May; 68():881-3. PubMed ID: 14443236
    [No Abstract]   [Full Text] [Related]  

  • 31. Mel W, a new trypanosomicidal agent derived from mel B.
    FRIEDHEIM EA; DE JONGH RT
    Trans R Soc Trop Med Hyg; 1959 May; 53(3):262-9. PubMed ID: 13669031
    [No Abstract]   [Full Text] [Related]  

  • 32. [Adrenaline in the prevention and treatment of adverse effects of arsobal therapy. Apropos of 776 cases of human African trypanosomiasis caused by T. gambiense in the Health Service of Fontem (U.R. Cameroon)].
    Sina GC; Triolo N; Cramet B; Suh Bandu M
    Med Trop (Mars); 1982; 42(5):531-6. PubMed ID: 7154902
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The treatment of T. rhodesiense sleeping sickness, with special reference to its physio-pathological and epidemiological basis.
    Buyst H
    Ann Soc Belg Med Trop; 1975; 55(2):95-104. PubMed ID: 1164053
    [No Abstract]   [Full Text] [Related]  

  • 34. The value of drugs commonly used in the treatment of T. rhodesiense sleeping sickness.
    SILVA MA
    An Inst Med Trop (Lisb); 1957; 14(1-2):159-70. PubMed ID: 13521347
    [No Abstract]   [Full Text] [Related]  

  • 35. Chemotherapy of sleeping sickness.
    Cent Afr J Med; 1979 Nov; 25(11):251. PubMed ID: 544029
    [No Abstract]   [Full Text] [Related]  

  • 36. The importance of 2,3-dimercaptopropinol (British anti-lewisite, BAL) in the trypanocidal activity of topical melarsoprol.
    Jennings FW; Atouguia JM; Murray M
    Acta Trop; 1996 Oct; 62(2):83-9. PubMed ID: 8988309
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Furaltadone in the treatment of Rhodesian sleeping sickness.
    ADRIAENSSENS K
    Trop Geogr Med; 1962 Jun; 14():171-82. PubMed ID: 13859470
    [No Abstract]   [Full Text] [Related]  

  • 38. Trypanosoma brucei brucei: the response to Melarsoprol in mice with cerebral trypanosomiasis. An immunopathological study.
    Poltera AA; Hochmann A; Lambert PH
    Clin Exp Immunol; 1981 Nov; 46(2):363-74. PubMed ID: 7039886
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mel B toxicity in human trypanosomiasis in the Gboko endemic area of Nigeria.
    Aiyedun BA; Amodu AA
    Acta Trop; 1976; 33(1):96-100. PubMed ID: 13638
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Preliminary report of 3 cases of Rhodesian sleeping sickness treated with NF-902 (a levo-isomer of furaltadone).
    ADRIAENSSENS K
    Ann Soc Belg Med Trop (1920); 1962 Feb; 42():31-7. PubMed ID: 13859471
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.